Tag | Content |
---|
EnhancerAtlas ID | HS170-00630 |
Organism | Homo sapiens |
Tissue/cell | RS4-11 |
Coordinate | chr11:60243910-60246120 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Foxo1 | MA0480.1 | chr11:60245728-60245739 | TCCTGTTTACT | + | 6.32 | MEF2C | MA0497.1 | chr11:60244224-60244239 | ATTTTAAAAATAGCA | + | 6.41 | Mafb | MA0117.2 | chr11:60245160-60245172 | AATTTGCTGACT | + | 6.22 | Myod1 | MA0499.1 | chr11:60244603-60244616 | TGCAGCTGTTTCC | + | 6.19 | Myog | MA0500.1 | chr11:60244602-60244613 | CTGCAGCTGTT | - | 6.02 | Tcf12 | MA0521.1 | chr11:60244602-60244613 | CTGCAGCTGTT | - | 6.62 | ZNF263 | MA0528.1 | chr11:60245881-60245902 | TCTCCCTTCACATCCTCCCCC | - | 6.91 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_10517 | chr11:60243810-60245768 | CD19_Primary | SE_11283 | chr11:60243573-60247114 | CD20 | SE_60853 | chr11:60243338-60270895 | DHL6 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr11 | 60244259 | 60244400 | chr11 | 60244400 | 60244754 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH11I060476 | chr11 | 60244042 | 60245363 |
|
Enhancer Sequence | TAGCCTACCC TTGTGCCAGT CACTAAGTTT TGATCAATCA AATGTAGTCA ACTGTTCAAA 60 CCGTGATCAA ATAAGGTAAT GTCAACCTGT AACCAATCCA ACTGTTTCTC TACCTTATTT 120 CCTTTTCTGT ACATCACTTT TCCTTTTCTG TTCATAAATC TTCTTCCACC ACGTGACTGT 180 GCTGGAGTCT CTGAGCCTCT GGCTAGAGGA GGGGCTGCCC GATTCGCGCA TCATTCATTG 240 CTCAATTAAA CGCCTTTAAA TTTAATTTGG CTGAAGTTTT TCTTTTATCA GTACAGCTGC 300 CGTGAAAACT AGTGATTTTA AAAATAGCAT GCATCCTAGG TTAGAATGCT AAACGCCTGC 360 GGAAAACTCA ATTCTGCTGA ACTCTACTCC ATTTTGTCCT GTTCAATGAG AGCCTTTTTT 420 TGAATTTGTC TTTCTCAGAG CTTTGCTAAT TAAACATTTT CAAGAGAACT CAGGAAAGAA 480 AAAGTCTTTA AGAGAATCTC TTGCAGTTCC ACACTGGCAA ACAAAAGGCC TGCAAAATAG 540 TATATCCTAG ATGGATCTTA GCTTTTTTTT TTTTTTTTTG ACAAGCACCT AATTCAAATT 600 TAAAAGAAGA AAAATTGTGT GTTGCATTCA ATGTCTTAAT AAAGTTTTCT GTCATCTCGT 660 GATGCATTGT TCCTGTCATC AATTCTGATT TACTGCAGCT GTTTCCTGCA AAACGCAAAA 720 GCGTAACTTC AACAAGTTTC ATTTCCTATA AAGATAAAAG TACAGAAAGT TGTGGATACA 780 TCTCTGGGCA AATCTGTTAC TGCAGAAGCT GATGAAAAAT GGTGCCAGAG CTATTTACGC 840 AATGAGAGCT TTCTGATGCT TTAGGGCTGG GGACTTCTCG TTTCCTTGAT CTCACCTGGT 900 TCATGGAGCA GTATCGTTCT TGTCATTGAT GCTGCACCTC AGAGATTTGT TGCTACTGTA 960 TTGGCTGTTG TGGTTGTTTC CATCAAAGAT GAGCAAGAAT TGCTTTGAAG AAAATTTTAC 1020 AACACCCAAT TGTCAATGAG TTATTATAAG TGATATGACT GAACTTTAGC TCTAAGTGAA 1080 TAGAAGTGTC TAAATTACAC CTGCACCATC CTCTTGACTA CTCACTAGTG AGATGGAGAC 1140 TAATTCATCT AAATTCTCTA CACTTCACAA AGGCAGGAAT TCTTGTCTAT GTTGTTTACT 1200 CCTATATACA CAGCACTTAG TACCAAGCAC ATGGAAAGCT GAATTTGTTG AATTTGCTGA 1260 CTGAATGTAG CCCTTTTATC TAGCTGTGTC TGTAGGCTCT AGACCTTCCA CCATTCTGAG 1320 GTAATTGCTT GCCTAGATGC TCGTGCAAAC CATTGAATTC TCTCTCTCCT GTCCTTCACA 1380 ACCAAACAAC TCAAAAGCAG AGTCTGCTTT CAGGTTTGAA TGTTTTCATA TCGCGTTCAT 1440 TTTTCAGTGA ATTACAGTCT GTCTATTCTC TCTAATACTT TTCTAGAATT GTTTCCCCAA 1500 ATGCTGCCAA TGACTTCTTA ATTGTTGAAT CCAGTGGATT CTACTCAATT CTCATTCTGT 1560 GAGATTTAAC AACACTGCCC TTTTGCTTCC TTGCCTTTTG AGACACATGC CCTTCCTTAG 1620 CTTCCAAGAT GGGACACTCT TAACTCTCTC TCCTACTTTC TTAGACATAC ACAATTTCAT 1680 CTTCACTAGT TGCATTTTTT CTGACAACCA AATGTGCACA TTCCTTACAA AGTGTTACCT 1740 TCCCCCAAAA ACTCTCATCC ATTCCCATAA CTCAGTCTAT CAATTTTAGG TAACTAATTC 1800 ATGTAATTGC ATTTTCAATC CTGTTTACTC ATCTGATTTC CAAGCCTGCA TGTCCGGGTA 1860 TTTGCAAATT ATTTCATAAT GATCTCCTAT CTGCAATGTA AAACTATAGA GCTGGTCCAG 1920 TCTGAGCCCG CGGTCTAATT CCCATGCACC TCCTTTTTAG CTTCCTGTCT CTCTCCCTTC 1980 ACATCCTCCC CCATCATCCA CACTCACAGC TGAGAGATGT ATTTGATTTA TTCCTTTTTC 2040 ACTCTTTTTA TCTAATGAAG TTCCTCATGT ACTTTAAGTT TTGTCTACTC TAAAATGTCT 2100 CTAAAATCCA ACTCTCCTCT TCTTTCTAGT CTTCACTTTA GGCCTAGTTT CTCATTTGCT 2160 CCTGCTGTTT CACTTATTTT ATAAACGATT AATTGGAATT GTTACATCCC 2210
|